A novel approach to positron emission tomography in lung cancer.
18F-fluorodeoxyglucose positron emission tomography-computed tomography is integral to the staging of lung cancer. We describe the combined use of diagnostic preoperative 18F-fluorodeoxyglucose positron emission tomography-computed tomography, intraoperative 18F-fluorodeoxyglucose handheld gamma probe detection, and immediate postoperative 18F-fluorodeoxyglucose positron emission tomography-computed tomography patient and specimen imaging for improved staging and determination of adequacy of mediastinal lymph node dissection.
Moffatt-Bruce
Susan D
SD
Division of Cardiothoracic Surgery, Department of Surgery, Arthur G. James Cancer Hospital Columbus, Ohio, USA. susan.moffatt-bruce@osumc.edu
Povoski
Stephen P
SP
Sharif
Suhail
S
Hall
Nathan C
NC
Ross
Patrick
P
Johnson
Morgan A
MA
Martin
Edward W
EW
D000369:Aged, 80 and over; D001707:Biopsy, Needle; D019788:Fluorodeoxyglucose F18; D005500:Follow-Up Studies; D015902:Gamma Cameras; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000601:surgery*; D008198:Lymph Nodes / Q000000981:diagnostic imaging / Q000473:pathology*; D008297:Male; D009367:Neoplasm Staging; D011013:Pneumonectomy / Q000379:methods; D049268:Positron-Emission Tomography / Q000379:methods*; D011182:Postoperative Care / Q000379:methods; D011300:Preoperative Care / Q000379:methods; D012680:Sensitivity and Specificity; D013908:Thoracotomy / Q000379:methods; D016896:Treatment Outcome; D051598:Whole Body Imaging
D019788:Fluorodeoxyglucose F18